Inflammation

Items 61-70 of 1901

per page
Set Descending Direction
  1. anti-7-Ketocholesterol [7-KC], mAb (35A)
    JAI-MKC-020N.
    JAI-MKC-020N20 µg
    CHF 830.00
    Immunohistochemical staining of 7KC in atherosclerotic aorta using anti-7-KC, mAb (35A).
  2. anti-8-Hydroxy-2'-deoxyguanosine [8-OHdG], mAb (N45.1)
    JAI-MOG-020P.
    JAI-MOG-020P20 µg
    CHF 260.00
    Immunohistochemical staining of epidermis from hairless mouse by chronic UVB irradiation after 4 weeks of treatment using anti-8-OHdG, mAb (N45.1).
  3. anti-8-Hydroxy-2'-deoxyguanosine [8-OHdG], mAb (N45.1)
    JAI-MOG-100P.
    JAI-MOG-100P100 µg
    CHF 995.00
    anti-8-Hydroxy-2'-deoxyguanosine [8-OHdG], mAb (N45.1)
  4. anti-Acrolein [ACR], mAb (5F6)
    JAI-MAR-100N.
    JAI-MAR-100N100 µg
    CHF 2'070.00
  5. anti-Acrolein [ACR], mAb (5F6)
    JAI-MAR-020N.
    JAI-MAR-020N20 µg
    CHF 518.00
  6. anti-Activin Receptor IIB, pAb (IG-510)
    AG-25T-0114
    AG-25T-0114-C05050 µg
    CHF 470.00
    Western blot with extracellular domains (ecd) of different related human receptors (50ng per lane) reveals that anti-Activin Receptor IIB, pAb (IG-510) (Prod. No. AG-25T-0114) (dilution 1:5000) specifically recoginzes ACTR-IIB under nonreducing (-ßME, lef
  7. anti-AIM2 (human), mAb (3B10)
    AG-20B-0040
    AG-20B-0040-C100100 µg
    CHF 330.00
  8. anti-APRIL (human), mAb (blocking) (Mahya-1) (preservative free)
    AG-20B-0078PF
    AG-20B-0078PF-C100100 µg
    CHF 490.00
    AG-20B-0078PF-C500500 µg
    CHF 1'200.00
    anti-APRIL (human), mAb (blocking) (Mahya-1) (preservative free)
  9. anti-APRIL (mouse), mAb (blocking) (Centotto-1) (preservative free)
    AG-20B-0083PF
    AG-20B-0083PF-C100100 µg
    CHF 470.00
    AG-20B-0083PF-C500500 µg
    CHF 1'100.00
  10. anti-APRIL (mouse), mAb (rec.) (blocking) (Apry-1-1)
    AG-27B-0001
    AG-27B-0001-C100100 µg
    CHF 455.00
    Schematic antibody structure.

Items 61-70 of 1901

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.